Exact Mass: 429.0914

Exact Mass Matches: 429.0914

Found 23 metabolites which its exact mass value is equals to given mass value 429.0914, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sulfamethoxazole N1-glucuronide

3,4,5-Trihydroxy-6-[N-(5-methyl-1,2-oxazol-3-yl)4-aminobenzenesulphonamido]oxane-2-carboxylic acid

C16H19N3O9S (429.0842)

Sulfamethoxazole N1-glucuronide is a metabolite of Sulfamethoxazole. Sulfamethoxazole n1-glucuronide belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.

Q63396586

C17H15N7O5S (429.0855)

SMZ-PtO

C17H15N7O5S (429.0855)

CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3103 ALGAE_TP_ID 3103; CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b)

Sulfamethoxazole glucuronide

1-[(4-amino-benzenesulfonyl)-(5-methyl-isoxazol-3-yl)-amino]-ξ-D-1-deoxy-glucopyranuronic acid

C16H19N3O9S (429.0842)

Anthrimide

1,1-Iminodianthra-9,10-quinone

C28H15NO4 (429.1001)

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

C19H19N5O3S2 (429.0929)

resorcin blue, pure

C24H15NO7 (429.0848)

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

C13H31Cl2NO6P2 (429.1004)

Funapide

C22H14F3NO5 (429.0824)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H19ClF3N5S (429.1002)

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

C19H19N5O3S2 (429.0929)

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

C19H19N5O3S2 (429.0929)

3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile

C24H15NO7 (429.0848)

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

C21H20ClN3O3S (429.0914)

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

C21H20ClN3O3S (429.0914)

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

C23H16ClN5O2 (429.0992)

3-Dehydroisovitexin

C21H17O10- (429.0822)

Sulfamethoxazole N1-glucuronide

1-[(4-amino-benzenesulfonyl)-(5-methyl-isoxazol-3-yl)-amino]-ξ-D-1-deoxy-glucopyranuronic acid

C16H19N3O9S (429.0842)

UBP316

C20H19N3O6S (429.0995)

UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].